Showing results (1-10 of 23,410) with videos related to

Sort By:
Pageof 2,341
The Journal of Infectious Diseases|August 18, 2001
Mannose-binding lectin accelerates complement activation and increases serum killing of Neisseria meningitidis serogroup CD L Jack, G A Jarvis, C L Booth, et al.
The Journal of Infectious Diseases|August 18, 2001
Evidence for superantigen involvement in severe group a streptococcal tissue infectionsA Norrby-Teglund, P Thulin, B S Gan, et al.
The Journal of Infectious Diseases|July 1, 1975
Depressed lymphocyte function after measles-mumps-rubella vaccinationT P Munyer, R J Mangi, T Dolan, et al.
The Journal of Infectious Diseases|August 23, 2001
Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapyA Weinberg, D A Wohl, R J Barrett, et al.
The Journal of Infectious Diseases|August 23, 2001
Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosisD H Dockrell, M Lee, D H Lynch, et al.
The Journal of Infectious Diseases|August 23, 2001
Nosocomial outbreak of Microbacterium species bacteremia among cancer patientsJ Alonso-Echanove, S S Shah, A J Valenti, et al.
The Journal of Infectious Diseases|August 23, 2001
Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphismM E Helminen, S Kilpinen, M Virta, et al.
The Journal of Infectious Diseases|August 23, 2001
Cholera in the United States, 1995-2000: trends at the end of the twentieth centuryE B Steinberg, K D Greene, C A Bopp, et al.
The Journal of Infectious Diseases|July 27, 2001
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitisR P Garofalo, J Patti, K A Hintz, et al.
The Journal of Infectious Diseases|July 27, 2001
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic responseM L Shiffman, C M Hofmann, R K Sterling, et al.
Pageof 2,341